Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
PLoS ONE2010Vol. 5(2), pp. e9015–e9015
Citations Over TimeTop 10% of 2010 papers
Richard A. Koup, Mario Roederer, Laurie Lamoreaux, Jennifer Fischer, Laura Novik, Martha Nason, Brenda Larkin, Mary E. Enama, Julie E. Ledgerwood, Robert T. Bailer, John R. Mascola, Gary J. Nabel, Barney S. Graham, the VRC 009 and VRC 010 Study Teams
Abstract
ClinicalTrials.gov NCT00102089, NCT00108654.
Related Papers
- → Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity(2006)109 cited
- → Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig(2011)33 cited
- → Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles(2007)28 cited
- → Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine(2008)8 cited
- Influence of HIV-1CN54 Gp145 deglycosylation on its immunogenicity(2013)